Patents by Inventor JENNIFER JOY RAHN

JENNIFER JOY RAHN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DPEP-1 Binding Compositions and Methods of Use
    Publication number: 20240108686
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: June 5, 2023
    Publication date: April 4, 2024
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing SZE Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • DPEP-1 binding compositions and methods of use
    Patent number: 11666631
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: June 6, 2023
    Assignee: Arch Biopartners, Inc.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing Sze Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • DPEP-1 BINDING AGENTS AND METHODS OF USE
    Publication number: 20220251140
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: February 14, 2022
    Publication date: August 11, 2022
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Daniel Abraham Muruve, Saurav Roy Choudhury, Jennifer Joy Rahn, Arthur Wing Sze Lau, Justin MacDonald, Liane Babes, Paul Kubes
  • DPEP-1 binding agents and methods of use
    Patent number: 11286278
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: March 29, 2022
    Assignee: Arch BioPartners, Inc.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Daniel Abraham Muruve, Saurav Roy Choudhury, Jennifer Joy Rahn, Arthur Wing Sze Lau, Justin MacDonald, Liane Babes, Paul Kubes
  • Peptides that block leukocyte recruitment and methods of use
    Patent number: 11083773
    Abstract: Disclosed are novel peptides comprising SEQ ID NO: 1 and modifications thereof, which are effective in blocking leukocyte recruitment. The disclosed peptides are useful for treating diseases associated with leukocyte recruitment for example inhibiting metastasis of a solid tumor to the liver and lungs and for treating sepsis. Also disclosed are methods of screening for compounds having the ability to block leukocyte recruitment.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: August 10, 2021
    Assignee: ARCH CANCER THERAPEUTICS, INC.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Paul Kubes
  • DPEP-1 BINDING AGENTS AND METHODS OF USE
    Publication number: 20200223888
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: December 2, 2019
    Publication date: July 16, 2020
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Daniel Abraham Muruve, Saurav Roy Choudhury, Jennifer Joy Rahn, Arthur Wing Sze Lau, Justin MacDonald, Liane Babes, Paul Kubes
  • DPEP-1 Binding Compositions and Methods of Use
    Publication number: 20200078442
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: July 8, 2019
    Publication date: March 12, 2020
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing SZE Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • Peptides that Block Leukocyte Recruitment and Methods of Use
    Publication number: 20200038473
    Abstract: Disclosed are novel peptides comprising SEQ ID NO: 1 and modifications thereof, which are effective in blocking leukocyte recruitment. The disclosed peptides are useful for treating diseases associated with leukocyte recruitment for example inhibiting metastasis of a solid tumor to the liver and lungs and for treating sepsis. Also disclosed are methods of screening for compounds having the ability to block leukocyte recruitment.
    Type: Application
    Filed: September 13, 2018
    Publication date: February 6, 2020
    Applicant: ARCH CANCER THERAPEUTICS, INC.
    Inventors: STEPHEN MARK ROBBINS, DONNA LORRAINE SENGER, JENNIFER JOY RAHN, PAUL KUBES
  • DPEP-1 binding compositions and methods of use
    Patent number: 10493127
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: December 3, 2019
    Assignee: Arch Biopartners, Inc.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing Sze Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • DPEP-1 BINDING COMPOSITIONS AND METHODS OF USE
    Publication number: 20170258872
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: August 11, 2016
    Publication date: September 14, 2017
    Inventors: STEPHEN MARK ROBBINS, DONNA LORRAINE SENGER, JENNIFER JOY RAHN, ARTHUR WING SZE LAU, DANIEL ABRAHAM MURUVE, SAURAV ROY CHOUDHURY
  • PEPTIDES THAT BLOCK LEUKOCYTE RECRUITMENT AND METHODS OF USE
    Publication number: 20170072006
    Abstract: Disclosed are novel peptides comprising SEQ ID NO: 1 and modifications thereof, which are effective in blocking leukocyte recruitment. The disclosed peptides are useful for treating diseases associated with leukocyte recruitment for example inhibiting metastasis of a solid tumor to the liver and lungs and for treating sepsis. Also disclosed are methods of screening for compounds having the ability to block leukocyte recruitment.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 16, 2017
    Applicant: ARCH CANCER THERAPEUTICS, INC.
    Inventors: STEPHEN MARK ROBBINS, DONNA LORRAINE SENGER, JENNIFER JOY RAHN, PAUL KUBES
  • Peptides that block leukocyte recruitment and methods of use
    Patent number: 9464114
    Abstract: Disclosed are novel peptides comprising SEQ ID NO: 1 and modifications thereof, which are effective in blocking leukocyte recruitment. The disclosed peptides are useful for treating diseases associated with leukocyte recruitment for example inhibiting metastasis of a solid tumor to the liver and lungs and for treating sepsis. Also disclosed are methods of screening for compounds having the ability to block leukocyte recruitment.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: October 11, 2016
    Assignee: ARCH CANCER THERAPEUTICS, INC.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Paul Kubes
  • PEPTIDES THAT BLOCK LEUKOCYTE RECRUITMENT AND METHODS OF USE
    Publication number: 20150225459
    Abstract: Disclosed are novel peptides comprising SEQ ID NO: 1 and modifications thereof, which are effective in blocking leukocyte recruitment. The disclosed peptides are useful for treating diseases associated with leukocyte recruitment for example inhibiting metastasis of a solid tumor to the liver and lungs and for treating sepsis. Also disclosed are methods of screening for compounds having the ability to block leukocyte recruitment.
    Type: Application
    Filed: February 13, 2015
    Publication date: August 13, 2015
    Applicant: ARCH CANCER THERAPEUTICS, INC.
    Inventors: STEPHEN MARK ROBBINS, DONNA LORRAINE SENGER, JENNIFER JOY RAHN, PAUL KUBES